<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>30(11)</volume><submitter>Martins Simoes P</submitter><pubmed_abstract>Background&lt;i>Staphylococcus haemolyticus&lt;/i> (SH) is an opportunistic pathogen associated with nosocomial infections, particularly bacteraemia in neonates. Epidemiological trends and genetic diversity of these infections worldwide are largely unknown.AimTo investigate an increase in SH vascular catheter-related bacteraemia in neonates and describe the molecular epidemiology in France between 2019 and 2023.MethodsWe analysed clinical and microbiological surveillance data from the French national surveillance network for central catheter-related (venous and umbilical) infections between 2019 and 2023. We also performed genomic and phylogenetic analyses of 496 strains isolated both inside (n = 383 from neonates, staff and environmental samples) and outside (n = 113 from adults) the neonatal i</pubmed_abstract><journal>Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11927072</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Epidemiology of &amp;lt;i&amp;gt;Staphylococcus haemolyticus&amp;lt;/i&amp;gt; nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage.</pubmed_title><pmcid>PMC11927072</pmcid><pubmed_authors>Ranc AG</pubmed_authors><pubmed_authors>Vernet-Garnier V</pubmed_authors><pubmed_authors>Fascia P</pubmed_authors><pubmed_authors>Romano-Bertrand S</pubmed_authors><pubmed_authors>Leyssene D</pubmed_authors><pubmed_authors>Verhoeven P</pubmed_authors><pubmed_authors>Canouet S</pubmed_authors><pubmed_authors>Barreto C</pubmed_authors><pubmed_authors>Benet C</pubmed_authors><pubmed_authors>Lamoureux C</pubmed_authors><pubmed_authors>Menard C</pubmed_authors><pubmed_authors>Lecuyer H</pubmed_authors><pubmed_authors>Menard G</pubmed_authors><pubmed_authors>Donnio PY</pubmed_authors><pubmed_authors>Kolenda C</pubmed_authors><pubmed_authors>Vandenesch F</pubmed_authors><pubmed_authors>Dubois D</pubmed_authors><pubmed_authors>Bailly P</pubmed_authors><pubmed_authors>Cavalie L</pubmed_authors><pubmed_authors>Idri N</pubmed_authors><pubmed_authors>Vacher S</pubmed_authors><pubmed_authors>Bourgeois-Nicolaos N</pubmed_authors><pubmed_authors>Youenou B</pubmed_authors><pubmed_authors>Laurent F</pubmed_authors><pubmed_authors>Grattard F</pubmed_authors><pubmed_authors>Pailhories H</pubmed_authors><pubmed_authors>Deroin V</pubmed_authors><pubmed_authors>Fais T</pubmed_authors><pubmed_authors>Liberge M</pubmed_authors><pubmed_authors>Beauruelle C</pubmed_authors><pubmed_authors>Boileau P</pubmed_authors><pubmed_authors>Ledru S</pubmed_authors><pubmed_authors>Lemarie C</pubmed_authors><pubmed_authors>Dumont Y</pubmed_authors><pubmed_authors>van der Mee-Marquet N</pubmed_authors><pubmed_authors>Tristan A</pubmed_authors><pubmed_authors>Motte-Signoret E</pubmed_authors><pubmed_authors>Dupin C</pubmed_authors><pubmed_authors>Stordeur F</pubmed_authors><pubmed_authors>Maurin E</pubmed_authors><pubmed_authors>Martins Simoes P</pubmed_authors><pubmed_authors>Chagneau C</pubmed_authors><pubmed_authors>Gibert L</pubmed_authors><pubmed_authors>Grisi B</pubmed_authors><pubmed_authors>S. haemolyticus neonatal infections Study Group</pubmed_authors><pubmed_authors>Bertrand X</pubmed_authors><pubmed_authors>Cisse A</pubmed_authors><pubmed_authors>Lefflot S</pubmed_authors><pubmed_authors>Sauget M</pubmed_authors><pubmed_authors>Lawrence C</pubmed_authors><pubmed_authors>Le Glass E</pubmed_authors><pubmed_authors>Muggeo A</pubmed_authors><pubmed_authors>Labbe F</pubmed_authors><pubmed_authors>Mourlan C</pubmed_authors><pubmed_authors>Butin M</pubmed_authors><pubmed_authors>Dupieux-Chabert C</pubmed_authors><pubmed_authors>Berger-Carbonne A</pubmed_authors><pubmed_authors>Gaudichon A</pubmed_authors><pubmed_authors>Mezard I</pubmed_authors><pubmed_authors>Cheron M</pubmed_authors><pubmed_authors>Le Bars H</pubmed_authors><pubmed_authors>Plainvert C</pubmed_authors><pubmed_authors>Miquel C</pubmed_authors><pubmed_authors>Lecorche E</pubmed_authors><pubmed_authors>Lehours P</pubmed_authors><pubmed_authors>Laurens E</pubmed_authors><pubmed_authors>Bernard E</pubmed_authors><pubmed_authors>Tazi A</pubmed_authors><pubmed_authors>Lafeuille E</pubmed_authors><pubmed_authors>Le Bouedec S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiology of &amp;lt;i&amp;gt;Staphylococcus haemolyticus&amp;lt;/i&amp;gt; nosocomial bacteraemia in neonatal intensive care units, France, 2019 to 2023: predominance of the ST29 (CC3) multidrug-resistant lineage.</name><description>Background&lt;i>Staphylococcus haemolyticus&lt;/i> (SH) is an opportunistic pathogen associated with nosocomial infections, particularly bacteraemia in neonates. Epidemiological trends and genetic diversity of these infections worldwide are largely unknown.AimTo investigate an increase in SH vascular catheter-related bacteraemia in neonates and describe the molecular epidemiology in France between 2019 and 2023.MethodsWe analysed clinical and microbiological surveillance data from the French national surveillance network for central catheter-related (venous and umbilical) infections between 2019 and 2023. We also performed genomic and phylogenetic analyses of 496 strains isolated both inside (n = 383 from neonates, staff and environmental samples) and outside (n = 113 from adults) the neonatal i</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Mar</publication><modification>2026-06-01T06:04:43.683Z</modification><creation>2026-04-08T09:44:16.054Z</creation></dates><accession>S-EPMC11927072</accession><cross_references><pubmed>40116031</pubmed><doi>10.2807/1560-7917.ES.2025.30.11.2400309</doi></cross_references></HashMap>